Status:
COMPLETED
The Study of Abatacept in Combination With Etanercept
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The Study was designed to look at the safety and efficacy of abatacept in combination with etanercept.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All subjects who had completed the short term portion of IM101-101.
Exclusion
Key Trial Info
Start Date :
October 1 2000
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT00162279
Start Date
October 1 2000
End Date
February 1 2007
Last Update
December 6 2010
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Huntsville, Alabama, United States
2
Local Institution
La Jolla, California, United States
3
Local Institution
Long Beach, California, United States
4
Local Institution
Los Angeles, California, United States